GeminIQ Website Logo

Viewing RYTM free

Subscribe for full history, 90+ metrics, screener, watchlist...

RHYTHM PHARMACEUTICALS, INC.

RYTM

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
666254521361068948162536065
Short Term Investments
265278335364155208231251157148216235
Accounts Receivable Net Current
403426332618191918151515
Inventory Net
312926221919191412998
Prepaid Expense And Other Assets Current
25272624251816991198
Assets Current
427430467495361369374340357236308329
Property Plant And Equipment Net
011000111112
Operating Lease Right Of Use Asset
333333344111
Finite Lived Intangible Assets Net
555666667777
Restricted Cash
111110000000
Other Long Term Investments
23322771213141515
Assets
437442480507373387392364382259333354
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
1612141416121255854
Accrued Liabilities And Other Liabilities
948084846959635548454844
Other Liabilities Current
--0-40393837----
Operating Lease Liability Current
1111100-1111
Deferred Revenue Current
000--1111111
Long Term Debt Current
131076422-----
Liabilities Current
1241031061041291121169855545550
Deferred Revenue Noncurrent
-------109108107106105
Liabilities Noncurrent
Long Term Debt Noncurrent
9398101103106108108---106-
Operating Lease Liability Noncurrent
333444443001
Derivative Liabilities
--0---0-0111
Other Liabilities Noncurrent
--------3635--
Liabilities
220205210211239224228211202197163157
Temporary Equity Carrying Amount Attributable To P…
114115131147145144143141140---
Stockholders Equity
Preferred Stock Value
00----------
Common Stock Value
000000000000
Additional Paid In Capital
1,5611,5301,4921,4541,2421,2241,1771,1241,1081,0981,0641,051
Accumulated Other Comprehensive Income Loss Net Of…
-10-1-1-2-0-0-1-1-00-0
Retained Earnings Accumulated Deficit
-1,457-1,408-1,352-1,304-1,251-1,205-1,155-1,112-1,068-1,036-895-853
Stockholders Equity
103123139149-121922113962170197
Liabilities And Stockholders Equity
437442480507373387392364382259333354
Series Convertible Preferred Stock
-------00---
Seriesa Convertible Preferred Stock
---00000000-
Series A Convertible Preferred Stock
-00--00-----
Preferred Stock Par Or Stated Value Per Share
0.0010.001-0.0010.0010.001-0.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
1010-101010-1010101010
Preferred Stock Shares Outstanding
00-000-00000
Preferred Stock Shares Issued
00-000-00000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
120120120120120120120120120120120120
Common Stock Shares Issued
696867676463626161615959
Shares Outstanding
696867676463626161615959

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-4.32%18.99%10.61%---------
2025-5.11%-2.94%33.76%16.46%11.96%24.73%3.91%4.77%-2.02%-10.83%-9.56%-7.70%
2024-9.33%4.35%24.65%7.38%16.60%10.24%-0.97%-11.27%-7.77%-5.23%12.44%9.14%
2023------23.25%67.68%61.77%-6.61%-12.46%-12.57%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
3.45
4.17
4.41
4.75
2.79
3.30
3.24
3.49
6.53
4.35
5.58
6.57
Quick Ratio
3.00
3.63
3.92
4.31
2.45
2.97
2.94
3.25
6.15
3.99
5.27
6.26
Working Capital
302.98M
326.89M
360.97M
390.54M
231.23M
257.47M
258.68M
242.74M
302.64M
181.59M
253.07M
279.06M
Leverage & Debt
Debt to Equity
2.14
1.67
1.51
1.42
-20.08
11.80
10.48
18.80
5.14
3.20
0.96
0.79
Interest Coverage TTM
-10.86
-9.99
-9.33
-8.48
-7.90
-8.12
-12.89
-13.99
-15.73
-17.43
-13.27
-14.79
Debt Ratio
0.50
0.46
0.44
0.42
0.64
0.58
0.58
0.58
0.53
0.76
0.49
0.44
Efficiency & Turnover
Asset Turnover TTM
0.59
0.52
0.43
0.40
0.41
0.42
0.36
0.31
0.29
0.30
0.22
0.17
Days Sales Outstanding TTM
50.61
43.71
42.89
54.79
51.05
43.36
46.81
54.89
56.35
45.29
49.71
52.61
Receivables Turnover TTM
7.21
8.35
8.51
6.66
7.15
8.42
7.80
6.65
6.48
8.06
7.34
6.94
Per Share Metrics
Diluted EPS TTM
-3.01
-3.00
-3.02
-2.90
-2.88
-2.68
-4.27
-4.25
-4.27
-4.55
-3.20
-3.21
Free Cash Flow Per Share TTM
-2.06
-2.35
-2.40
-1.64
-1.07
-2.44
-3.19
-3.35
-3.42
-3.02
-2.38
-2.45
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
89.00%
89.41%
89.73%
89.40%
89.25%
89.62%
89.73%
88.61%
88.80%
88.37%
87.99%
88.55%
Operating Profit Margin TTM
-83.62%
-90.89%
-101.19%
-106.81%
-113.53%
-126.13%
-204.04%
-235.95%
-260.93%
-295.58%
-238.10%
-298.77%
Net Profit Margin TTM
-85.93%
-93.84%
-103.57%
-110.37%
-117.19%
-123.28%
-200.27%
-231.24%
-256.16%
-297.93%
-238.52%
-299.33%
Growth Metrics
Net Revenue Growth (1Y)
53.51%
58.67%
45.83%
54.92%
53.55%
48.88%
68.06%
81.55%
132.57%
173.52%
227.56%
271.94%
Net Income Growth (1Y)
12.57%
20.78%
-24.58%
-26.06%
-29.76%
-38.39%
41.11%
40.25%
43.07%
51.70%
1.97%
2.23%
EPS Growth (1Y)
4.51%
12.04%
-29.21%
-31.68%
-32.70%
-41.24%
33.43%
32.58%
33.36%
43.04%
-7.85%
-9.21%
Valuation Metrics
P/E TTM
-36.94
-29.01
-35.39
-34.78
-21.97
-19.80
-13.10
-12.33
-9.61
-9.52
-14.36
-7.15
P/B TTM
73.95
48.10
50.02
44.97
-337.94
176.29
157.14
285.98
63.67
42.32
15.62
6.72
P/S TTM
31.74
27.22
36.66
38.38
25.75
24.41
26.24
28.50
24.61
28.35
34.24
21.41
Market Cap
7.62B
5.91B
6.96B
6.69B
4.02B
3.34B
3.41B
3.21B
2.51B
2.61B
2.65B
1.33B
Enterprise Value
7.66B
5.96B
7.01B
6.75B
4.00B
3.34B
3.44B
3.16B
2.34B
2.55B
2.70B
1.26B
Calculated Values
Free Cash Flow TTM
-141.51M
-159.51M
-155.68M
-108.78M
-67.87M
-153.99M
-194.38M
-204.92M
-208.46M
-181.34M
-137.08M
-141.70M
Net Debt
40.49M
46.33M
53.88M
56.89M
-25.79M
3.43M
20.67M
-47.52M
-161.67M
-53.43M
46.06M
-64.59M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-22Sale
Owner: Tetrault, Lynn A.
Title: -
Shares: 37,000
Price/Share: $100.32
Value: $3,711,840.00
Shares Owned: 7,000
Relationship: Director
Ownership: Direct
2026-05-15Sale
Owner: German, Christopher Paul
Title: Corporate Controller & CAO
Shares: 4,643
Price/Share: $92.21
Value: $428,131.03
Shares Owned: -
Relationship: Officer
Ownership: Direct
2026-03-04Sale
Owner: German, Christopher Paul
Title: Corporate Controller & CAO
Shares: 5,614
Price/Share: $89.56
Value: $502,789.84
Shares Owned: 160
Relationship: Officer
Ownership: Direct
2026-02-19Sale
Owner: Smith, Hunter C
Title: Chief Financial Officer
Shares: 4,385
Price/Share: $101.64
Value: $445,691.40
Shares Owned: 110,512
Relationship: Officer
Ownership: Direct
2026-02-12Sale
Owner: Smith, Hunter C
Title: Chief Financial Officer
Shares: 1,592
Price/Share: $98.26
Value: $156,429.92
Shares Owned: 118,466
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
102.74%
Inst. Shares: 69,837,233
Shares Outstanding: 67,974,193
2025-12-31
108.59%
Inst. Shares: 70,563,571
Shares Outstanding: 64,984,361
2025-09-30
104.22%
Inst. Shares: 69,060,165
Shares Outstanding: 66,261,055
2025-06-30
100.94%
Inst. Shares: 64,284,540
Shares Outstanding: 63,684,359
2025-03-31
98.69%
Inst. Shares: 62,231,393
Shares Outstanding: 63,059,165

RHYTHM PHARMACEUTICALS, INC. (RYTM) — SEC Financial Statements & Analysis

RHYTHM PHARMACEUTICALS, INC. (RYTM) is a pharmaceutical preparations company, incorporated in DE. RHYTHM PHARMACEUTICALS, INC. trades on Nasdaq as: RYTM. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), RHYTHM PHARMACEUTICALS, INC. reported a 53.51% year-over-year revenue growth, a Gross Profit Margin of 89.00% (TTM), a Debt-to-Equity ratio of 2.14x, a Price-to-Sales (P/S) ratio of 31.74x (TTM), a Price-to-Book (P/B) ratio of 73.95x (TTM), at a market cap of $7.62B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
53.51%
Gross Profit Margin TTM
89.00%
Debt To Equity
2.14x
P/S TTM
31.74x
P/B TTM
73.95x
Market Cap
$7.62B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is RHYTHM PHARMACEUTICALS, INC. in?

RHYTHM PHARMACEUTICALS, INC. (RYTM) operates in the Pharmaceutical Preparations industry.

What is RYTM's market cap?

RHYTHM PHARMACEUTICALS, INC. (RYTM) has a market capitalization of $7.62B as of 2026-06-30.

What exchange does RYTM trade on?

RHYTHM PHARMACEUTICALS, INC. (RYTM) trades on the Nasdaq.

Where is RHYTHM PHARMACEUTICALS, INC. incorporated?

RHYTHM PHARMACEUTICALS, INC. is incorporated in DE.

Wall Street's data.
Main Street's price.